Literature DB >> 27614330

Mother-child interaction and cognitive development in children prenatally exposed to methadone or buprenorphine.

Carolien Konijnenberg1, Monica Sarfi2, Annika Melinder3.   

Abstract

OBJECTIVE: To assess the influence of mother-child interaction on children's cognitive development in a group of children prenatally exposed to methadone or buprenorphine. STUDY
DESIGN: The study is part of a prospective longitudinal project investigating the development of children born to women in opioid maintenance therapy (OMT). The sample includes 67 children born between 2005 and 2007, 35 of which prenatally exposed to either methadone or buprenorphine and 32 non-exposed comparison children.
RESULTS: Both groups scored within the normal range of development. However, the OMT group scored significantly lower on measures of cognitive development and mother-child interaction compared to the comparison group. Cognitive development was found to be affected by both group status, F(1,54)=5.65, p=0.02, η(2)=0.10 and mother-child interaction F(1,54)=5.26, p=0.03, η(2)=0.09. Behavioral inhibition (statue), sensorimotor function (imitating hand positions), and short-term memory (sentences) was influenced by group status while narrative memory and vocabulary were found to be more influenced by mother-child interaction.
CONCLUSIONS: Different risk factors may influence different cognitive functions in children of women in OMT. Specifically, language-related cognitive skills may be more related to mother-child interaction while performance in higher cognitive functions requiring precise control over sensorimotor responses may be more sensitive to other factors such as prenatal OMT exposure, genetics, and/or prenatal exposure to other substances.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27614330     DOI: 10.1016/j.earlhumdev.2016.08.013

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  13 in total

1.  Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.

Authors:  Ludmila N Bakhireva; Bradley D Holbrook; Shikhar Shrestha; Yuridia Leyva; Malia Ashley; Sandra Cano; Jean Lowe; Julia M Stephen; Lawrence Leeman
Journal:  Early Hum Dev       Date:  2018-12-13       Impact factor: 2.079

Review 2.  Efficacy of Direct or Indirect Use of Probiotics for the Improvement of Maternal Depression during Pregnancy and in the Postnatal Period: A Systematic Review and Meta-Analysis.

Authors:  Klavdija Čuček Trifkovič; Dušanka Mičetić-Turk; Sergej Kmetec; Maja Strauss; Hannah G Dahlen; Jann P Foster; Sabina Fijan
Journal:  Healthcare (Basel)       Date:  2022-05-24

Review 3.  Modeling prenatal opioid exposure in animals: Current findings and future directions.

Authors:  Elizabeth M Byrnes; Fair M Vassoler
Journal:  Front Neuroendocrinol       Date:  2017-09-28       Impact factor: 8.606

Review 4.  Prenatal Opioid Exposure: Neurodevelopmental Consequences and Future Research Priorities.

Authors:  Elisabeth Conradt; Tess Flannery; Judy L Aschner; Robert D Annett; Lisa A Croen; Cristiane S Duarte; Alexander M Friedman; Constance Guille; Monique M Hedderson; Julie A Hofheimer; Miranda R Jones; Christine Ladd-Acosta; Monica McGrath; Angela Moreland; Jenae M Neiderhiser; Ruby H N Nguyen; Jonathan Posner; Judith L Ross; David A Savitz; Steven J Ondersma; Barry M Lester
Journal:  Pediatrics       Date:  2019-09       Impact factor: 9.703

5.  Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic.

Authors:  Svetlana Skurtveit; Blanka Nechanská; Marte Handal; Milada Mahic; Viktor Mravčík; Roman Gabrhelík
Journal:  Addiction       Date:  2019-03-12       Impact factor: 6.526

6.  Mothering, Substance Use Disorders and Intergenerational Trauma Transmission: An Attachment-Based Perspective.

Authors:  Florien Meulewaeter; Sarah S W De Pauw; Wouter Vanderplasschen
Journal:  Front Psychiatry       Date:  2019-10-18       Impact factor: 4.157

7.  Neurobehavior of newborn infants exposed prenatally to methadone and identification of a neurobehavioral profile linked to poorer neurodevelopmental outcomes at age 24 months.

Authors:  Trecia A Wouldes; Lianne J Woodward
Journal:  PLoS One       Date:  2020-10-16       Impact factor: 3.240

8.  Infant neurodevelopmental outcomes of prenatal opioid exposure and polysubstance use.

Authors:  Madelyn H Labella; Rina D Eiden; Alexandra R Tabachnick; Tabitha Sellers; Mary Dozier
Journal:  Neurotoxicol Teratol       Date:  2021-06-08       Impact factor: 4.071

9.  Maternal verbal scaffolding: association with higher language skills for 20-month-old children with prenatal polysubstance exposure.

Authors:  Jean R Lowe; Lauren Hund; Dominique E Rodriguez; Asma Qamruddin; Lawrence Leeman; Julia M Stephen; Ludmila N Bakhireva
Journal:  Early Hum Dev       Date:  2021-07-04       Impact factor: 2.699

Review 10.  Will Widespread Synthetic Opioid Consumption Induce Epigenetic Consequences in Future Generations?

Authors:  Federica Gilardi; Marc Augsburger; Aurelien Thomas
Journal:  Front Pharmacol       Date:  2018-07-03       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.